1. Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization
- Author
-
Floriana Bonura, Simona De Grazia, Celestino Bonura, Giuseppa L. Sanfilippo, Giovanni M. Giammanco, Emanuele Amodio, Donatella Ferraro, Bonura, Floriana, De Grazia, Simona, Bonura, Celestino, Sanfilippo, Giuseppa L, Giammanco, Giovanni, Amodio, Emanuele, and Ferraro, Donatella
- Subjects
Settore MED/07 - Microbiologia E Microbiologia Clinica ,Vaccines, Synthetic ,COVID-19 Vaccines ,SARS-CoV-2 ,Vaccination ,COVID-19 ,General Medicine ,neutralizing antibodies ,Settore MED/42 - Igiene Generale E Applicata ,Antibodies, Viral ,Antibodies, Neutralizing ,Applied Microbiology and Biotechnology ,Kinetics ,Italy ,healthcare worker ,Immunoglobulin G ,Spike Glycoprotein, Coronavirus ,Humans ,mRNA Vaccines ,kinetics of antibodie ,BNT162 Vaccine ,Biotechnology - Abstract
Aims Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has had a serious worldwide impact on human health. On December 2020, an immunization campaign with a COVID-19 mRNA vaccine (Comirnaty-BNT162b2 Pfizer-BioNTech) was started in Italy, first targeting healthcare workers (HCWs). This study aims to investigate the antibodies that are response against SARS-CoV-2 vaccine. Methods and Results The kinetics and the persistence of both anti-S1/S2 IgGs and neutralizing antibodies (Nt-Abs) were investigated in 76 HCWs through a 4-month follow-up with multiple testing points starting at the first dose. Temporal analysis of SARS-CoV-2 Abs titre kinetics showed three different stages, with an initial slow growth in the anti-S1/S2 IgGs and Nt-Abs titres, corresponding to the first 4 weeks after the first dose of vaccine, followed by a second stage with peaks in titres, around 35 days after the first dose, and by a third stage (38 to 90–120 days after the first dose) showing a steady decrease in anti-S1/S2 IgGs while Nt-Abs are maintained at stable levels. Moreover, the levels of specific Nt-Abs to SARS-CoV-2 Spike protein are correlated to the anti-S1/S2 IgG titre (R-squared = 0.47; p < 0.001). Conclusions The levels of specific Nt-Abs to SARS-CoV-2 Spike protein are correlated to the anti-S1/S2 IgG titre, although Nt-Abs could maintain a more stable titre over the time despite declining IgG Abs titre. Significance and Impact This study highlights the kinetics and the persistence of Nt-Abs in HCWs vaccinated with Comirnaty (BNT162b2) Pfizer-BioNTech, and compared the Nt-Abs levels with anti-SARS-CoV-2 S1/S2 IgGs titres during a 4-month follow-up starting at the first dose of vaccine.
- Published
- 2022
- Full Text
- View/download PDF